Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Other Non-Current Liabilities: 2023

  • Upstream Bio's Other Non-Current Liabilities was N/A to $2.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Upstream Bio's Other Non-Current Liabilities is $2.9 million.
  • Upstream Bio's 5-year Other Non-Current Liabilities high stood at $2.9 million for Q4 2023, and its period low was $2.9 million during Q4 2023.
  • Its 1-year average for Other Non-Current Liabilities is $2.9 million, with a median of $2.9 million in 2023.